A Hybrid Feature Selection Approach to Screen a Novel Set of Blood Biomarkers for Early COVID-19 Mortality Prediction
The increase in coronavirus disease 2019 (COVID-19) infection caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has placed pressure on healthcare services worldwide. Therefore, it is crucial to identify critical factors for the assessment of the severity of COVID-19 infection an...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-06-01
|
Series: | Diagnostics |
Subjects: | |
Online Access: | https://www.mdpi.com/2075-4418/12/7/1604 |
_version_ | 1827624075494686720 |
---|---|
author | Asif Hassan Syed Tabrej Khan Nashwan Alromema |
author_facet | Asif Hassan Syed Tabrej Khan Nashwan Alromema |
author_sort | Asif Hassan Syed |
collection | DOAJ |
description | The increase in coronavirus disease 2019 (COVID-19) infection caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has placed pressure on healthcare services worldwide. Therefore, it is crucial to identify critical factors for the assessment of the severity of COVID-19 infection and the optimization of an individual treatment strategy. In this regard, the present study leverages a dataset of blood samples from 485 COVID-19 individuals in the region of Wuhan, China to identify essential blood biomarkers that predict the mortality of COVID-19 individuals. For this purpose, a hybrid of filter, statistical, and heuristic-based feature selection approach was used to select the best subset of informative features. As a result, minimum redundancy maximum relevance (mRMR), a two-tailed unpaired <i>t</i>-test, and whale optimization algorithm (WOA) were eventually selected as the three most informative blood biomarkers: International normalized ratio (INR), platelet large cell ratio (P-LCR), and D-dimer. In addition, various machine learning (ML) algorithms (random forest (RF), support vector machine (SVM), extreme gradient boosting (EGB), naïve Bayes (NB), logistic regression (LR), and k-nearest neighbor (KNN)) were trained. The performance of the trained models was compared to determine the model that assist in predicting the mortality of COVID-19 individuals with higher accuracy, F1 score, and area under the curve (AUC) values. In this paper, the best performing RF-based model built using the three most informative blood parameters predicts the mortality of COVID-19 individuals with an accuracy of 0.96 ± 0.062, F1 score of 0.96 ± 0.099, and AUC value of 0.98 ± 0.024, respectively on the independent test data. Furthermore, the performance of our proposed RF-based model in terms of accuracy, F1 score, and AUC was significantly better than the known blood biomarkers-based ML models built using the Pre_Surv_COVID_19 data. Therefore, the present study provides a novel hybrid approach to screen the most informative blood biomarkers to develop an RF-based model, which accurately and reliably predicts in-hospital mortality of confirmed COVID-19 individuals, during surge periods. An application based on our proposed model was implemented and deployed at Heroku. |
first_indexed | 2024-03-09T12:01:46Z |
format | Article |
id | doaj.art-831ad41f09ac4f1ea1052b747fd788e8 |
institution | Directory Open Access Journal |
issn | 2075-4418 |
language | English |
last_indexed | 2024-03-09T12:01:46Z |
publishDate | 2022-06-01 |
publisher | MDPI AG |
record_format | Article |
series | Diagnostics |
spelling | doaj.art-831ad41f09ac4f1ea1052b747fd788e82023-11-30T23:03:10ZengMDPI AGDiagnostics2075-44182022-06-01127160410.3390/diagnostics12071604A Hybrid Feature Selection Approach to Screen a Novel Set of Blood Biomarkers for Early COVID-19 Mortality PredictionAsif Hassan Syed0Tabrej Khan1Nashwan Alromema2Department of Computer Science, Faculty of Computing and Information Technology Rabigh (FCITR), King Abdulaziz University, Jeddah 22254, Saudi ArabiaDepartment of Information Systems, Faculty of Computing and Information Technology Rabigh (FCITR), King Abdulaziz University, Jeddah 22254, Saudi ArabiaDepartment of Computer Science, Faculty of Computing and Information Technology Rabigh (FCITR), King Abdulaziz University, Jeddah 22254, Saudi ArabiaThe increase in coronavirus disease 2019 (COVID-19) infection caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has placed pressure on healthcare services worldwide. Therefore, it is crucial to identify critical factors for the assessment of the severity of COVID-19 infection and the optimization of an individual treatment strategy. In this regard, the present study leverages a dataset of blood samples from 485 COVID-19 individuals in the region of Wuhan, China to identify essential blood biomarkers that predict the mortality of COVID-19 individuals. For this purpose, a hybrid of filter, statistical, and heuristic-based feature selection approach was used to select the best subset of informative features. As a result, minimum redundancy maximum relevance (mRMR), a two-tailed unpaired <i>t</i>-test, and whale optimization algorithm (WOA) were eventually selected as the three most informative blood biomarkers: International normalized ratio (INR), platelet large cell ratio (P-LCR), and D-dimer. In addition, various machine learning (ML) algorithms (random forest (RF), support vector machine (SVM), extreme gradient boosting (EGB), naïve Bayes (NB), logistic regression (LR), and k-nearest neighbor (KNN)) were trained. The performance of the trained models was compared to determine the model that assist in predicting the mortality of COVID-19 individuals with higher accuracy, F1 score, and area under the curve (AUC) values. In this paper, the best performing RF-based model built using the three most informative blood parameters predicts the mortality of COVID-19 individuals with an accuracy of 0.96 ± 0.062, F1 score of 0.96 ± 0.099, and AUC value of 0.98 ± 0.024, respectively on the independent test data. Furthermore, the performance of our proposed RF-based model in terms of accuracy, F1 score, and AUC was significantly better than the known blood biomarkers-based ML models built using the Pre_Surv_COVID_19 data. Therefore, the present study provides a novel hybrid approach to screen the most informative blood biomarkers to develop an RF-based model, which accurately and reliably predicts in-hospital mortality of confirmed COVID-19 individuals, during surge periods. An application based on our proposed model was implemented and deployed at Heroku.https://www.mdpi.com/2075-4418/12/7/1604COVID-19blood biomarkershybrid-feature selectionfilter-based feature selectiontwo-tailed unpaired <i>t</i>-testmeta-heuristic method |
spellingShingle | Asif Hassan Syed Tabrej Khan Nashwan Alromema A Hybrid Feature Selection Approach to Screen a Novel Set of Blood Biomarkers for Early COVID-19 Mortality Prediction Diagnostics COVID-19 blood biomarkers hybrid-feature selection filter-based feature selection two-tailed unpaired <i>t</i>-test meta-heuristic method |
title | A Hybrid Feature Selection Approach to Screen a Novel Set of Blood Biomarkers for Early COVID-19 Mortality Prediction |
title_full | A Hybrid Feature Selection Approach to Screen a Novel Set of Blood Biomarkers for Early COVID-19 Mortality Prediction |
title_fullStr | A Hybrid Feature Selection Approach to Screen a Novel Set of Blood Biomarkers for Early COVID-19 Mortality Prediction |
title_full_unstemmed | A Hybrid Feature Selection Approach to Screen a Novel Set of Blood Biomarkers for Early COVID-19 Mortality Prediction |
title_short | A Hybrid Feature Selection Approach to Screen a Novel Set of Blood Biomarkers for Early COVID-19 Mortality Prediction |
title_sort | hybrid feature selection approach to screen a novel set of blood biomarkers for early covid 19 mortality prediction |
topic | COVID-19 blood biomarkers hybrid-feature selection filter-based feature selection two-tailed unpaired <i>t</i>-test meta-heuristic method |
url | https://www.mdpi.com/2075-4418/12/7/1604 |
work_keys_str_mv | AT asifhassansyed ahybridfeatureselectionapproachtoscreenanovelsetofbloodbiomarkersforearlycovid19mortalityprediction AT tabrejkhan ahybridfeatureselectionapproachtoscreenanovelsetofbloodbiomarkersforearlycovid19mortalityprediction AT nashwanalromema ahybridfeatureselectionapproachtoscreenanovelsetofbloodbiomarkersforearlycovid19mortalityprediction AT asifhassansyed hybridfeatureselectionapproachtoscreenanovelsetofbloodbiomarkersforearlycovid19mortalityprediction AT tabrejkhan hybridfeatureselectionapproachtoscreenanovelsetofbloodbiomarkersforearlycovid19mortalityprediction AT nashwanalromema hybridfeatureselectionapproachtoscreenanovelsetofbloodbiomarkersforearlycovid19mortalityprediction |